• Leadership

Ramsay Health Care Board and Global Leadership

Board Members

Michael S Siddle
Michael Siddle
Chairman

Appointed 27/05/14 (Appointed as a Director 26/5/75)

Mr Michael Siddle was appointed as Chairman of the Company on 27 May 2014, having formerly been Deputy Chairman for 17 years and a founding Director. He has built up significant knowledge of the business and the private hospital industry after starting with the Company in 1968. Mr Siddle has extensive experience in the management of private hospitals and has been integrally involved in Ramsay Health Care’s successful expansion through construction, mergers and acquisitions.

Mr Siddle is also a Director of the Paul Ramsay Foundation.

Committee memberships:

  • People & Remuneration Committee (Member)
  • Nomination & Governance Committee (Member)

Independence status:

  • Non-independent
Craig McNally
Craig McNally
CEO & Managing Director
Appointed 03/07/17
Mr Craig McNally was appointed Managing Director and Chief Executive Officer of Ramsay Health Care (Ramsay) on 3 July 2017, after serving seven years with Ramsay Health Care as Chief Operating Officer and 22 years prior to this in various roles including Head of Global Strategy and European Operations.
 
Mr McNally is one of Ramsay’s longest serving Executives having commenced with the Company in 1988. He has worked across operational, strategic and financial roles during his tenure.
 
For the last two decades has been responsible for the development and implementation of Ramsay’s growth strategy including brownfield expansions, international market assessments, mergers and acquisitions and new business strategies. He has been at the forefront of all the major acquisitions and deals completed by Ramsay Health Care. His unique ability to assess the opportunities and risks associated with new business ventures and to evaluate their ‘strategic fit’, as well as his sound judgement and insight, has ensured the Company’s successful growth both domestically and internationally.
 
He has been a key leader in the development of The Ramsay Way culture and in particular developing leadership capability within the global organisation.
David Thodey AO
David Thodey AO
Non-Executive Director (Appointed 28/11/17) and
Lead Independent Director (Appointed 1/03/20)

Mr David Thodey AO is a business leader who has had an executive career in the technology and telecommunications industries, with more than 30 years of experience creating brand and shareholder value.

In addition to being a Non-Executive Director and Lead Independent Director of Ramsay Health Care, Mr Thodey is currently Chair of Tyro Payments Limited (a leading alternative payments provider) and Xero Limited (a small business accounting software company).

Mr Thodey was previously CEO of Telstra, Australia’s leading telecommunications and information services company, Chair of Australia’s national scientific research agency, the Commonwealth Scientific and Industrial Research Organisation (CSIRO) and prior to that he was CEO of IBM ANZ.

Mr Thodey holds a Bachelor of Arts in Anthropology and English from Victoria University, Wellington, New Zealand, attended the Kellogg School of Management postgraduate General Management Program at Northwestern University in Chicago, USA, and was awarded an Honorary Doctorate in Science and Technology from Deakin University in 2016 and an Honorary Doctorate of Business from University of Technology Sydney in 2018.

Mr Thodey is also a Fellow of the Australian Academy of Technological Sciences and Engineering (ATSE) and the Australian Institute of Company Directors (AICD).

Mr Thodey was awarded an Order of Australia in 2017 for his service to business and the promotion of ethical leadership and workplace diversity.

In the past three years, Mr Thodey has served as a Director of the following listed companies:

  • Xero Limited (Appointed June 2019)
  • Tyro Payments Limited (Appointed November 2018)
  • Vodafone Group Plc (Resigned July 2020)

Mr Thodey is the Lead Independent Director and is a member of the following Committees:

  • Nomination and Governance Committee (Chair)
  • Audit Committee (Member)
  • People & Remuneration Committee (Member)
  • Risk Management Committee (Member)

Independence Status:

  • Independent
Claudia Süssmuth Dyckerhoff
Claudia Süssmuth Dyckerhoff PhD
Non-Executive Director
Appointed 30/10/18

Dr Claudia Süssmuth Dyckerhoff PhD joined the Ramsay Health Care Board in October 2018, bringing expertise in market growth strategies, business development, and operational performance improvement in hospitals.

Dr Süssmuth Dyckerhoff has extensive global experience in hospitals and health care across Europe, Asia, and the USA. She joined McKinsey & Company in Switzerland in 1995 and was transferred to the USA focusing on supporting health care companies, including pharmaceutical/medical device companies, payor, provider and health systems in Europe and the USA. In 2006, Dr Süssmuth Dyckerhoff transferred to China, was elected Senior Partner in 2010 and supported health care companies as well as governments across Asia. She also led McKinsey’s Asia-wide Health Systems and Services Sector. 

Dr Süssmuth Dyckerhoff also supports start-ups in the Healthcare area, she joined the board of the Health Tech company HUMA in April 2021 and joined the board of QuEST Global in November 2020.

Dr Süssmuth Dyckerhoff studied Business Administration at the University of St Gallen, Switzerland as well as at ESADE, Barcelona where she graduated with an MBA/CEMS Master. She also holds a PhD in Business Administration from the University of St Gallen/University of Michigan Ann Arbor.

In the past three years, Dr Süssmuth Dyckerhoff has served as a Director of the following listed companies:

  • Hoffmann La Roche (Appointed March 2016)
  • Clariant AG (Appointed April 2016)

Committee memberships:

  • Risk Management Committee (Member)

Independence status:

  • Independent
Alison Deans
Alison Deans MA MBA GAICD
Non-Executive Director
Appointed 15/11/18

Alison Deans has 25 years’ experience building technology-enabled businesses involved in media, ecommerce, financial services and health, and across leadership roles as an executive, a director and in venture capital.

Ms Deans joined the Board of Ramsay Health Care in November 2018. She is also Chair of Cochlear Limited and a Non-Executive Director of SCEGGS Darlinghurst and Deputy Pty Ltd. She is also on the Investment Committee of MainSequence Ventures.

In her executive career Ms Deans was previously the CEO of eBay Australia and New Zealand, CEO of eCorp Limited, (a publicly listed portfolio of digital businesses), CEO of Hoyts Cinemas, and most recently CEO of netus Pty Ltd - a technology investment company acquired by Fairfax.

Ms Deans also spent seven years as a Consultant with McKinsey & Company and is currently a Senior Advisor with the firm. She holds a Master of Business Administration from the Stanford

Graduate School of Business and a Master of Arts (Physics) from Cambridge University.

In the past three years, Ms Deans has served as a Director of the following listed companies:

  • Cochlear Limited (Appointed February 2015)
  • Westpac Banking Corporation (Resigned December 2020)

Committee memberships:

  • People & Remuneration Committee (Chair)
  • Nomination and Governance Committee (Member)

Independence status:

  • Independent
James McMurdo
James McMurdo BSc (Economics), ACA
Non-Executive Director
Appointed 10/09/19

Mr James McMurdo has over 30 years finance and banking experience. He has a background in corporate advisory spanning across mergers and acquisitions, strategic advisory and financing with experience across multiple industries including the healthcare sector. He has held senior operating management roles and worked extensively in both the Asia Pacific and European regions.

Mr McMurdo is one of the Founding Partners of Privatus Capital Partners, an advisory and merchant banking business focussed on private capital. Prior to establishing Privatus, Mr McMurdo held senior management roles at Deutsche Bank and was based in Hong Kong. During the time he was at Deutsche Bank he was Global Co-Head of Corporate Finance, Head of Corporate and Investment Bank for Asia Pacific and CEO for Australia and New Zealand. He sat on the firm’s Global Executive Committee for the Corporate and Investment Bank for four years.

Prior to this, Mr McMurdo was a Partner at Goldman Sachs where he held senior positions in the Investment Banking Division in Australia and Europe.

Mr McMurdo holds a degree in Economics from the University of Newcastle upon Tyne and is a member of the Institute of Chartered Accountants for England & Wales.

Committee memberships:

  • Audit Committee (Member)

Independence status:

  • Independent
Karen Penrose
Karen Penrose B.Com (UNSW) CPA FAICD
Non-Executive Director
Appointed 1/3/20

Ms Karen Penrose has had an extensive executive career in leadership and CFO roles, mainly in financial services. She is well-versed in financial management, customer outcomes and operating in a rapidly changing regulatory environment which stems from 20 years in banking with Commonwealth Bank and HSBC and eight years as a listed-company CFO.

Ms Penrose has been a full-time director since 2014 and is an experienced committee chair of audit and risk. In addition to being a Non-Executive Director of Ramsay Health Care, Ms Penrose also serves as a Director of Vicinity Centres, Bank of Queensland and Estia Health. Ms Penrose is a member of Chief Executive Women and on the Board of Marshall Investments Pty Limited and Rugby Australia Limited.

In the past three years, Ms Penrose has served as a Director of the following listed companies:

  • Vicinity Centres (Appointed June 2015)
  • Bank of Queensland (Appointed November 2015)
  • Estia Health (Appointed October 2018)
  • Spark Infrastructure Group (Resigned May 2020)

Committee memberships:

  • Audit Committee (Chair)
  • Risk Management Committee (Chair)

Independence status:

  • Independent
Steven Sargent
Steven Sargent
Non-Executive Director

Appointed 25/11/21 

Mr Sargent’s executive career included 22 years at General Electric, where he gained extensive multi-industry, international experience leading businesses in industries including healthcare, energy and financial services across the USA, Europe and Asia Pacific. 

Mr Sargent has been serving as a non-executive director on several boards since 2015 and is currently a Non-Executive Director of Origin Energy Limited and Deputy Chairman and Lead Independent Director of infection prevention company Nanosonics Limited. He is also currently a Non-Executive Director and Chairman of OFX Group Limited, an international money services provider. Steve’s unlisted board activities include Chairman of The Origin Energy Foundation Limited, Origin’s philanthropic arm, and Non-Executive Director of The Great Barrier Reef Foundation.

Steve holds a Bachelor of Business from Charles Sturt University and is a Fellow with the Australian Institute of Company Directors and a Fellow with the Australian Academy of Technological Sciences and Engineering.

Committee memberships:

  • Risk Management Committee (Member)

Independence status:

  • Independent

Group General Counsel & Company Secretary

Henrietta Rowe
Henrietta Rowe B Econ (Soc Sci) (Hons), LLB (Hons), FGIA, MAICD
Group General Counsel & Company Secretary
Appointed 25/06/19

Henrietta was appointed Group General Counsel & Company Secretary on 25 June 2019 and is responsible for the Group legal, governance and secretariat functions.

Henrietta has more than 15 years’ experience with leading global law firm, Herbert Smith Freehills, and in-house at the Commonwealth Bank of Australia, specialising in mergers and acquisitions, capital management and corporate governance.

Henrietta holds a Bachelor of Economics (Social Sciences) (Honours) and a Bachelor of Laws (Honours) from the University of Sydney, is a Fellow of the Governance Institute of Australia and a member of the Australian Institute of Company Directors Law Committee.


Management Team

Craig McNally
Craig McNally
Managing Director & CEO

Mr Craig McNally was appointed Managing Director and Chief Executive Officer of Ramsay Health Care (Ramsay) on 3 July 2017, after serving seven years with Ramsay Health Care as Chief Operating Officer and 22 years prior to this in various roles including Head of Global Strategy and European Operations.

Mr McNally is one of Ramsay’s longest serving Executives having commenced with the Company in 1988. He was initially employed as a Hospital Executive in Ramsay’s Sydney-based mental health facilities, before taking over divisional responsibility for acute medical and surgical hospitals in the early nineties.

In 1995, he became Ramsay’s Head of Strategic Development, and for the last two decades has been responsible for the development and implementation of Ramsay’s growth strategy including brownfield expansions, international market assessments, mergers and acquisitions and new business strategies. As the Company’s chief negotiator and deal-maker he has been at the forefront of all the major acquisitions and deals completed by Ramsay Health Care. His unique ability to assess the opportunities and risks associated with new business ventures and to evaluate their ‘strategic fit’, as well as his sound judgement and insight, has ensured the Company’s successful growth both domestically and internationally.

In his role as head of Ramsay’s UK and European business, Mr McNally has been responsible for leading these teams through the challenging acquisition and merger phases and ensuring their successful integration with Ramsay Health Care and adoption of The Ramsay Way culture. His quiet but assured leadership style is well-respected throughout the organisation.

Prior to joining Ramsay Health Care in 1988, Mr McNally was an executive of a private hospital in Sydney following completion of a health administration degree at the University of New South Wales.

He is married with three children and an enthusiastic fan of football, baseball and rugby.

Martyn Roberts
Martyn Roberts
Group Chief Financial Officer

Martyn Roberts joined Ramsay Health Care in April 2020 as Group Chief Financial Officer. Prior to Ramsay, Martyn was Group Chief Financial Officer of Coca-Cola Amatil Ltd for five years.

Before Amatil, Martyn worked for seven years at Woolworths Ltd in various senior executive roles including Finance Director Supermarkets, General Manager of Woolworths Petrol and General Manager Corporate Strategy and Business Development. Prior to Woolworths, Martyn was in various senior finance roles in the fashion and luxury goods sector in Sydney, London, Hong Kong and Paris including nine years with Louis Vuitton.

After gaining a Bachelor of Science in Mathematics & Statistics from the University of York, Martyn began his career with Coopers and Lybrand in the UK where he became a member of the Institute of Chartered Accountants of England and Wales.

Martyn is also currently Joint Deputy Chair of the Group of 100 in Australia.

Colleen Harris
Colleen Harris
Group Chief People Officer

Mrs Colleen Harris commenced with Ramsay Health Care on 8 January 2018 in the role of Group Chief People Officer.

In this role, Colleen is responsible for the talent strategy for the Group including mapping of where key expertise will be needed in the future, talent development and succession planning for the most senior leaders across our organisation.

Colleen is a successful Human Resources (HR) executive with more than 20 years’ experience across a variety of industries where she was responsible for designing and implementing talent, diversity, performance and reward programmes linked to both individual and business performance outcomes. She has served in several senior executive HR positions reporting to the Group CEOs of National Australia Bank, Federation Centres and MyState Limited. She has also held senior HR positions at Crown Ltd and Yellow Pages.

She holds a Bachelor of Education (Science) from the University of Melbourne, is a Member of the AICD and a Fellow of the Australian Human Resources Institute.

In 2020 Colleen was appointed a Director of Ramsay Sime Darby Health Care, Ramsay Health Care’s joint venture with Sime Darby.

Professor Sir Edward Byrne
Professor Sir Edward Byrne AC FMedSci
Group Chief Medical Officer

Professor Ed Byrne is currently Global Chief Medical Officer for Ramsay health care group having succeeded Prof. John Horvath in February 2021. He is also vice-chancellor's distinguished fellow at ANU and serves as a non executive director on a number of boards and is a trustee of the Ian Potter foundation. Ed Byrne was President & Principal at King’s College London and Chairman of King’s Health Partners board from 1st August 2014 until early 2021.

He began his career in Adelaide after graduating with first class honours from the University of Tasmania in 1974. He was made Neurology Registrar at Royal Adelaide Hospital in 1978. He finished his neurology training and completed his doctorate at the Institute of Neurology Queen Square and in 1982 was awarded the Queen Square prize for neurological research. In 1983, he was appointed Director of Neurology at St Vincent's Hospital and Professor of Clinical Neurology at the University of Melbourne in 1992.

Professor Byrne was a founding director of the Melbourne Neuromuscular Research Unit and the Centre for Neuroscience in 1993. He was also made Professor of Experimental Neurology at the University of Melbourne in 2001. His major research contributions have been in the field of mitochondrial medicine and neuromuscular disorders. More recently he has worked on changes in universities and health systems to meet societal needs.

He first came to Monash University as the Dean of the Faculty of Medicine Nursing and Health Sciences, a role he held from 2003 until 2007.

Professor Byrne was then appointed the Vice Provost (Health) at University College London (UCL). He held that position until becoming the eighth University President and Vice-Chancellor at Monash University in 2009.

In the commercial world, Ed Byrne served for many years as a non executive director at Cochlear Ltd and also as a director of Bupa both in the UK and Australia. He has served on a number of research institute and charity boards.

The University of Melbourne awarded him a Doctor of Science, a higher degree conferred in recognition of a demonstrated record of research excellence. He completed a Masters of Business Administration in 2005. He has honorary professorships from UCL, Warwick University and Peking University and Honorary Degrees from the University of Adelaide, Warwick University, Western University and University of Sydney. He is a fellow of the Australian Academy of Science and Technology and the Australian Academy of Health and Medicine and is a fellow of the American Academy of Neurology and the American Neurological Association. He is a fellow of the Royal Australian College of physicians and the Royal Colleges of physicians of London and Edinburgh. He is emeritus professor of medicine at Monash University and neurology at King’s College London.

Professor Byrne was admitted as an Officer of the Order of Australia in 2006 and a Companion of the Order of Australia, Australia’s highest honour, in 2014.

He was elected as a Fellow of the Academy of Medical Sciences in the UK in 2019. He was awarded a Knighthood in the Queen’s Birthday Honours in October 2020 for contributions to higher education and healthcare.

He has wide interests in the arts and has published four books of poetry through Melbourne University Press and has recently co-authored with Charles Clarke, a former senior UK Cabinet Minister, a book “The University Challenge : Changing universities in a changing world”.

Dr Andrew Jones
Dr Andrew Jones
Group Chief Growth Officer

Dr Andrew Jones was appointed Group Chief Growth Officer in November 2021.

He moved into the new leadership position after four years as Chief Executive Officer of Ramsay UK. Prior to joining Ramsay, Dr Jones was Chief Operating Officer at Nuffield Health.

Dr Jones is a dynamic leader and strategic thinker, with deep corporate knowledge and extensive experience in strategic planning and implementation across consumer and healthcare industries.

As Ramsay’s Group Chief Growth Officer, Dr Jones is responsible for implementing the global business transformation strategy and developing new business opportunities across Ramsay’s high-quality health care services.

Carmel Monaghan
Carmel Monaghan
Chief Executive Officer Ramsay Australia

Carmel Monaghan was appointed Chief Executive Officer (CEO) of Ramsay Health Care’s (Ramsay) Australian operations on 1 October 2020. In Australia, Ramsay is a leading private health care operator with over 70 hospitals, 50 community pharmacies and employing over 30,000 staff.

Ms Monaghan has worked across hospital, corporate and global positions in Ramsay for over two decades. Prior to her appointment as CEO of Australia, Ms Monaghan was the Group Chief of Staff of Ramsay's global operations gaining extensive experience and a comprehensive understanding of health care operations and strategy both in Australia and overseas. She also served as the Group Head of Marketing and Public Affairs directing the Company’s marketing, brand and communications strategy through a time of several major mergers and acquisitions both within Australia and overseas as it grew from 12 facilities to over 500, becoming one of the leading private health care operators in the world.

In her time with Ramsay, Ms Monaghan has had a strong focus on delivering results through focusing on customers and developing strong doctor relationships. She is a respected leader with the ability to build an experienced and loyal team and her collaborative style and people-focused approach, is closely aligned with ‘The Ramsay Way’. Having worked with the company’s founder Paul Ramsay for many years, she has a strong belief in its organisational culture of ‘people caring for people’.

Prior to joining Ramsay, Ms Monaghan was the Manager Public Relations and Media for the Queensland Branch of the Australian Medical Association (AMAQ) for four years between 1994 and 1998.

Carmel holds a Bachelor of Business (Communications) and a Master of Business Administration. She has served as a board member of the Gallipoli Medical Research Foundation and the publicly listed Ramsay Santé.

Pascal Roché

Pascal Roché
Chief Executive Officer, Ramsay Santé


Mr Pascal Roché has been Générale de Santé Chief Executive Officer, the leading French publicly listed hospital operator, since June 2011. After Ramsay Health Care took interest in the company in October 2014, Mr Roché was appointed in charge of the merger of Générale de Santé with Ramsay Santé France and Chief Executive Officer of the future combined entity, Ramsay Santé, from June 2015.

Mr Roché is Ramsay Santé Group CEO, with, after the acquisition of Capio AB Group in 2018, 36000 employees and 8600 practioners serving 7 million patients in 350 facilities in five countries : France, Sweden, Norway, Denmark and Italy.

Mr Roché started his career in the consulting business from 1985 to 1991 and then held various senior executive positions in the insurance sector at Axa France from 1991 to 2002. From 2002 to 2010, he was Chairman and Chief Executive Officer of Barclays Bank France where he was also global head of three business lines between 2007 and 2011, covering 17 countries. In 2010-2011, he was appointed Chief Executive Officer of Barclays Spain.

Mr Roché graduated from HEC business school, and holds a Master in private law and a postgraduate in Economics and Organization strategy. He is also a qualified actuary.

Nick Costa
Nick Costa
Chief Executive Officer, Ramsay UK

Nick Costa was appointed Chief Executive Officer (CEO) of Ramsay Health Care UK in January 2022.

Mr Costa was Ramsay UK’s Chief Operating Officer from 2018 and has been instrumental in ensuring the effective operational delivery of the UK business. Most recently, he has overseen the successful rollout of a new Electronic Patient Record system across all Ramsay hospitals in the UK.

Mr Costa has extensive health industry experience and a proven track record as an accomplished and collaborative leader. Prior to joining Ramsay, he was the Regional Operations & Transformation Director at Nuffield Health, where he was responsible for delivering high quality services and standards and national business transformation.

Peter Hong
Peter Hong
Group Chief Executive Officer, Ramsay Sime Darby Health Care

Peter Hong joined Sime Darby Berhad’s Healthcare Division in 2019 and was appointed Group CEO in January 2022. He has 28 years’ experience in southeast Asia's healthcare sector including senior management roles with several multinational pharmaceutical and medical companies. A Chartered Accountant, Mr Hong holds a Bachelor of Economics (Accounting) from Monash University and is a Fellow of CPA Australia and the Malaysian Institute of Accountants.

Joy Chamberlain
Joy Chamberlain
Chief Executive Officer, Elysium Healthcare

Joy Chamberlain has led the specialist mental health care provider, Elysium Healthcare, since its formation in 2016. As CEO, she has grown the UK business to more than 70 sites offering a range of acute/complex mental health care, outpatient, rehabilitation and community care for public and private patients. A qualified Chartered Accountant, Ms Chamberlain has more than 20 years’ experience in the specialist healthcare sector. Prior to joining Elysium, she was CEO at the UK provider Partnerships in Care.

Elysium Healthcare was acquired by Ramsay Health Care in December 2021.

Find out more at www.elysiumhealthcare.co.uk

 

Global Organisational Structure